February 2026
1. FERREIRA AI, Arieira C, Campelo P, Xavier S, et al
   Three is not a crowd: improving the study of chronic constipation.
   Eur J Gastroenterol Hepatol. 2026 Feb 23. doi: 10.1097/MEG.0000000000003164.
   

   >> Share

   
   January 2026
2. AKRAM U, Ul Ain H, Ahmed S, Fatima E, et al
   Efficacy and tolerability of plecanatide for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis.
   Eur J Gastroenterol Hepatol. 2026 Jan 13. doi: 10.1097/MEG.0000000000003115.
   

   >> Share

   
   December 2025
3. ANWAR DFF, Salma ZN, Oktaviani SD, Adiyatma FN, et al
   Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: a systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes.
   Eur J Gastroenterol Hepatol. 2025 Dec 24. doi: 10.1097/MEG.0000000000003074.
   

   >> Share

   
   November 2025
4. AREF A, Aldemerdash MA, Mohamed I, Abdallfatah A, et al
   Efficacy and safety of tenapanor in the management of irritable bowel syndrome with constipation: a systematic review and meta-analysis.
   Eur J Gastroenterol Hepatol. 2025 Nov 26. doi: 10.1097/MEG.0000000000003107.
   

   >> Share

   
   
5. GOYAL O, Goyal MK, Gupta A, Bharadwaj A, et al
   Prevalence and predictors of nonceliac wheat sensitivity in refractory irritable bowel syndrome and functional dyspepsia: results from a randomized double-blind placebo-controlled study.
   Eur J Gastroenterol Hepatol. 2025;37:1238-1248.
   

   >> Share

   
   August 2025
6. ROKKAS T, Ekmektzoglou K, Tsanou E, Bricca L, et al
   Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable bowel syndrome: a systematic review and network meta-analysis.
   Eur J Gastroenterol Hepatol. 2025 Aug 25. doi: 10.1097/MEG.0000000000003062.
   

   >> Share

   
   April 2025
7. ARIF TB, Ali SH, Bhojwani KD, Sadiq M, et al
   Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis.
   Eur J Gastroenterol Hepatol. 2025 Apr 30. doi: 10.1097/MEG.0000000000002994.
   

   >> Share

   
   August 2024
8. LIPTAK P, Duricek M, Schnierer M, Ziacikova IL, et al
   Symptoms of functional dyspepsia and irritable bowel syndrome among medical students in Slovakia and their relation to diet and exercise.
   Eur J Gastroenterol Hepatol. 2024;36:985-992.
   

   >> Share

   
   July 2024
9. LIU T, Wang Z, Kang X, Wang X, et al
   Causal relationships between psychological disorders and functional gastrointestinal disorders: a bidirectional two-sample Mendelian randomization study.
   Eur J Gastroenterol Hepatol. 2024 Jul 8. doi: 10.1097/MEG.0000000000002825.
   

   >> Share

   
   November 2023
10. WANG YN, Zhou LY, Huang YH, Jiang M, et al
    The incidence and predisposing factors for irritable bowel syndrome following COVID-19: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2023 Nov 30. doi: 10.1097/MEG.0000000000002688.
    

    >> Share

    
    April 2023
11. YAMAMOTO Y, Furukawa S, Miyake T, Watanabe J, et al
    Exercise habits that include exercise partners and irritable bowel syndrome in a young Japanese population: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2023 Apr 17. doi: 10.1097/MEG.0000000000002561.
    

    >> Share

    
    January 2023
12. ROKKAS T, Hold GL
    A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome.
    Eur J Gastroenterol Hepatol. 2023 Jan 31. doi: 10.1097/MEG.0000000000002519.
    

    >> Share

    
    
13. SIYAL M, Abbas Z, Ashraf J, Ali Qadeer M, et al
    Incidence and predisposing factors for de novo post-COVID-19 irritable bowel syndrome.
    Eur J Gastroenterol Hepatol. 2023;35:59-63.
    

    >> Share

    
    September 2022
14. CHENG F, Fan Z, Lin C, Zhu Y, et al
    Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice.
    Eur J Gastroenterol Hepatol. 2022 Sep 12. pii: 00042737-990000000-00069.
    

    >> Share

    
    March 2022
15. HASSANIN TM, Fouad Y, Mohamed FE, Abdel-Hafeez EH, et al
    Colonic mucosal eosinophilia and immunohistochemical expression of COX-2 and NF-kB in patients with irritable bowel syndrome.
    Eur J Gastroenterol Hepatol. 2022 Mar 10. pii: 00042737-900000000-97082.
    

    >> Share

    
    February 2022
16. HURYCH J, Vodolanova L, Vejmelka J, Drevinek P, et al
    Freezing of faeces dramatically decreases the viability of Blastocystis sp. and Dientamoeba fragilis.
    Eur J Gastroenterol Hepatol. 2022;34:242-243.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share